Saturday 17 October 2026
Export RKDA’s income statement to Excel — free account
Arcadia Biosciences, Inc.
RKDA Consumer Defensive Packaged Foods
Arcadia Biosciences, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $4.9 million, down 3.71% from fiscal 2024. In the quarter to June 2026, revenue was flat, EPS grew 35.9% and free cash flow grew 82.1%, each against the same quarter a year earlier.
0.16
0.04
−20.00%
Follow RKDA
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
4 | 5 | 2 | 1 | 4 | 2 | 4 | 2 | 3 | 3 |
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Altman Z-Score |
(3.03) | (15.07) | (11.02) | (9.13) | (5.54) | (7.86) | (12.46) | (19.08) | (28.14) | (59.20) |
P/S ratio |
12.53 | 2.89 | 8.16 | 29.83 | 3.14 | 3.26 | 0.90 | 0.81 | 1.60 | 0.56 |
Altman Z″-Score (non-manufacturers) |
(4.57) | (33.17) | (22.31) | (19.79) | (11.29) | (15.14) | (24.78) | (41.36) | (64.94) | (136.50) |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2.51 |
P/Operating CF |
(9.34) | (4.34) | (4.43) | (6.96) | (3.73) | (3.32) | (2.85) | (0.87) | (3.65) | (3.15) |
Beneish M-Score |
(3.42) | (1.79) | (3.67) | (0.32) | 5.55 | — | (3.57) | (0.63) | 0.68 | (1.84) |
P/B ratio |
1.80 | 1.45 | 0.93 | 4.19 | 0.88 | 0.71 | 0.32 | 0.28 | 1.30 | 0.65 |
Price to Tangible BV |
1.80 | 1.45 | 0.93 | 4.19 | 0.91 | 0.72 | 0.32 | 0.28 | 1.30 | 0.66 |
EV/Sales |
4.56 | 4.89 | 7.64 | 8.28 | 0.35 | (0.95) | (1.86) | (1.78) | 0.78 | (0.36) |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.23 | 1.13 | 1.55 | 0.00 | 0.72 |
EV/Operating CF |
(0.85) | (1.41) | (0.82) | (0.56) | (0.09) | 0.25 | 0.99 | 0.52 | (0.41) | 0.37 |
EV/FCF |
(0.84) | (1.40) | (0.81) | (0.52) | (0.09) | 0.24 | 1.05 | 0.52 | (0.42) | (1.61) |
Quick Ratio |
16.33 | 4.04 | 7.20 | 4.54 | 4.29 | 5.96 | 5.19 | 3.38 | 2.11 | 2.42 |
Current Ratio |
16.69 | 4.27 | 7.49 | 4.98 | 5.02 | 7.02 | 6.03 | 4.17 | 3.61 | 3.09 |
Net Debt/EBITDA |
1.40 | 0.92 | 1.29 | 1.35 | 2.02 | 1.02 | 1.69 | 2.27 | 1.40 | 1.89 |
Debt/Assets |
44.41% | 0.00% | 0.00% | 0.40% | 6.86% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
1.13 | 0.00 | 0.00 | 0.02 | 0.11 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Asset Turnover |
0.05 | 0.11 | 0.07 | 0.04 | 0.20 | 0.15 | 0.20 | 0.18 | 0.30 | 0.48 |
Operating CF/Net income |
0.87 | 0.89 | 1.01 | 0.60 | 6.49 | 1.76 | 0.91 | 1.09 | 1.37 | 2.03 |
Capex/Depreciation |
(0.52) | (0.39) | 6.15 | (2.02) | (1.40) | (0.14) | 0.48 | 0.11 | 7.10 | 8.82 |
Interest Coverage |
(14.12) | (19.16) | — | (3,876.20) | (271.87) | (1,776.30) | 48.47 | — | — | — |
| (62.87%) | (104.00%) | (129.48%) | (272.50%) | (25.25%) | (49.07%) | (59.03%) | (83.21%) | (74.37%) | (45.14%) | |
| (30.00%) | (42.95%) | (66.41%) | (101.79%) | (11.65%) | (32.13%) | (42.22%) | (57.50%) | (42.37%) | (23.32%) | |
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | (130.26%) | (884.26%) | (3,419.68%) | (359.45%) | (115.09%) | 0.00% |
Return on Tangible Assets |
(39.56%) | (132.87%) | (66.68%) | (117.42%) | (16.10%) | (44.92%) | (70.31%) | (122.08%) | (104.73%) | (54.33%) |
Average Days of Receivables |
61.02 | 111.97 | 41.89 | 187.96 | 63.88 | 73.75 | 60.08 | 41.47 | 85.01 | 31.93 |
Research and Development Expense of Revenue |
271.74% | 183.98% | 414.55% | 607.19% | 99.08% | 57.36% | 20.34% | 1.44% | 1.05% | 0.19% |
Selling, General and Administrative Expense of Revenue |
384.25% | 264.56% | 792.62% | 1,160.56% | 204.97% | 338.32% | 202.70% | 184.87% | 191.10% | 144.11% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.02 | 0.01 | 0.00 | 0.00 | 0.00 | 0.01 |
Share Based Compensation of Revenue |
33.22% | 36.61% | 105.87% | 195.64% | 25.42% | 22.73% | 14.91% | 16.10% | 10.15% | 4.82% |
Graham Net Nets |
0.45 | 0.56 | 0.98 | 0.12 | 0.51 | 1.02 | 2.59 | 2.21 | 0.24 | 1.46 |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Earnings Yield |
(48.89%) | (136.85%) | (192.11%) | (83.21%) | (17.79%) | (62.50%) | (231.34%) | (489.35%) | (87.18%) | (86.36%) |
Free Cash Flow Yield |
(43.26%) | (120.59%) | (116.13%) | (53.50%) | (129.15%) | (121.35%) | (195.70%) | (421.82%) | (115.37%) | 39.84% |
Revenue per Share |
57.44 | 74.69 | 15.54 | 7.35 | 32.27 | 12.74 | 12.38 | 3.60 | 3.70 | 3.55 |
Operating CF per Share |
(307.30) | (259.09) | (144.70) | (108.10) | (121.36) | (48.62) | (23.33) | (12.36) | (7.06) | (3.46) |
Capex per Share |
(4.16) | (1.39) | (2.55) | (9.18) | (9.35) | (1.86) | 1.42 | 0.09 | 3.17 | 0.55 |
Free Cash Flow per Share |
(311.46) | (260.48) | (147.25) | (117.28) | (130.70) | (50.48) | (21.92) | (12.27) | (3.90) | (2.92) |
Cash per Share |
910.99 | 241.61 | 231.67 | 159.22 | 103.08 | 53.92 | 34.46 | 9.41 | 3.11 | 3.34 |
Shareholders Equity per Share |
399.96 | 148.55 | 136.04 | 52.33 | 114.67 | 58.64 | 34.89 | 10.27 | 4.57 | 3.03 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
399.96 | 148.55 | 136.04 | 52.33 | 114.67 | 58.64 | 34.89 | 10.27 | 4.57 | 3.03 |
Free Cash Flow |
(17.29) | (14.04) | (13.87) | (18.66) | (32.54) | (26.86) | (13.13) | (15.18) | (5.31) | (3.99) |
Working Capital |
49.09 | 11.52 | 19.82 | 22.73 | 25.38 | 30.35 | 21.19 | 11.38 | 6.68 | 4.30 |
Capital Expenditures |
(0.23) | (0.07) | (0.24) | (1.46) | (2.33) | (0.99) | 0.85 | 0.11 | 4.32 | 0.75 |
Net Current Asset Value |
17.85 | 6.48 | 11.67 | 4.19 | 12.90 | 22.67 | 17.38 | 7.97 | 1.95 | 3.95 |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.18 | 0.99 | 1.30 | 0.00 | 0.70 |
Capex to Sales |
0.07 | 0.02 | 0.16 | 1.25 | 0.29 | 0.15 | (0.11) | (0.02) | (0.86) | (0.15) |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.87 | 0.64 | (0.10) | 0.40 | 0.47 | 3.17 | 2.60 | 14.06 | 14.83 | 10.63 |
Cash ROIC |
(17.66%) | (66.76%) | (40.05%) | (55.22%) | (56.63%) | (44.85%) | (31.60%) | (62.37%) | (50.73%) | (45.83%) |
Accounts Receivable Turnover |
4.83 | 4.55 | 2.09 | 3.04 | 8.00 | 4.88 | 5.73 | 5.16 | 6.00 | 6.07 |
Accounts Payable Turnover |
0.37 | 0.12 | 0.26 | 0.24 | 1.18 | 2.25 | 1.88 | 0.91 | 1.47 | 1.59 |
Inventory Turnover |
3.28 | 1.18 | 3.22 | 0.90 | 1.85 | 2.11 | 1.81 | 1.38 | 3.40 | 2.93 |
Average Days of Payables |
962.05 | 3,219.22 | 1,460.55 | 1,932.23 | 288.19 | 152.49 | 170.80 | 320.68 | 259.68 | 210.78 |
Days of Inventory on Hand |
102.77 | 295.35 | 99.95 | 739.90 | 267.62 | 185.81 | 138.86 | 140.53 | 111.36 | 142.80 |
Average Receivables |
0.66 | 0.88 | 0.70 | 0.39 | 1.00 | 1.39 | 1.30 | 0.86 | 0.84 | 0.80 |
Average Payables |
2.39 | 2.43 | 2.57 | 3.67 | 4.40 | 3.87 | 3.25 | 2.38 | 2.01 | 1.95 |
Average Inventory |
0.27 | 0.24 | 0.21 | 0.99 | 2.80 | 4.12 | 3.38 | 1.58 | 0.87 | 1.06 |
Average Assets |
65.41 | 36.57 | 20.30 | 28.30 | 39.96 | 45.63 | 36.42 | 24.31 | 16.61 | 10.03 |
Average Common Equity |
31.21 | 15.10 | 10.41 | 10.57 | 18.44 | 29.87 | 26.05 | 16.80 | 9.46 | 5.18 |
Columns are period end dates